You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LOTS

Showing 1 - 25 of 688
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rabies, Prevention Trial (PIKA-adjuvanted inactivated rabies vaccine, Rabipur)

Not yet recruiting
  • Rabies
  • Prevention
  • PIKA-adjuvanted inactivated rabies vaccine
  • Rabipur
  • (no location specified)
Dec 28, 2022

Gastric Cancer, Gastric Adenocarcinoma, Effects of Chemo Trial in Taiwan (leucovorin, oxaliplatin, docetaxel, S-1)

Recruiting
  • Gastric Cancer
  • +3 more
  • leucovorin, oxaliplatin, docetaxel, S-1
  • Kaohsiung, Taiwan
  • +3 more
May 24, 2022

Hepatitis B Trial in Hanoi (Sci-B-Vac-Lot B, Sci-B-Vac-Lot A, Engerix-B)

Completed
Has Results
  • Hepatitis B
  • Sci-B-Vac-Lot B
  • +2 more
  • Hanoi, Vietnam
    National Institute of Hygiene and Epidemiology (NIHE)
Jul 18, 2022

Chikungunya Virus Infection Trial in United States (Biological Vaccine VLA1553)

Completed
  • Chikungunya Virus Infection
  • Biological Vaccine VLA1553
  • Coral Gables, Florida
  • +11 more
Jan 31, 2022

Respiratory Syncytial Virus Infections Trial in Canada, Sweden, United States (RSVPreF3 OA investigational vaccine)

Completed
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • Waterbury, Connecticut
  • +19 more
Aug 5, 2022

COVID-19 Trial in Yancheng (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml, Recombinant Novel

Active, not recruiting
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.3ml
  • Yancheng, Jiangsu, China
    Funing Center for Disease Control and Prevention
Oct 28, 2022

Coronavirus Infections, Healthy Trial in Valinhos (NDV-HXP-S 10µg, BNT162b2 30µg)

Not yet recruiting
  • Coronavirus Infections
  • Healthy
  • NDV-HXP-S 10μg
  • BNT162b2 30μg
  • Valinhos, São Paulo, Brazil
    Azidus Brasil Pesquisa Científica e Desenvolvimento Ltda.
May 16, 2022

COVID-19, SARS-CoV-2 Infection Trial in United States (NVX-Cov2373)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • Long Beach, California
  • +30 more
Jul 18, 2022

Malaria,Falciparum Trial in Silver Spring (Plasmodium falciparum malaria parasite)

Completed
Has Results
  • Malaria,Falciparum
  • Plasmodium falciparum malaria parasite
  • Silver Spring, Maryland
    Walter Reed Army Institute of Research
Mar 3, 2021

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2, BNT162b2.B.1.351)

Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • BNT162b2.B.1.351
  • Oakland, California
  • +16 more
Feb 17, 2022

HPV Infection Trial in Mianyang (Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Pichia pastoris))

Active, not recruiting
  • HPV Infection
  • Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Pichia pastoris)
  • Mianyang, Sichuan, China
    Mianyang Center for Disease Control and Prevention
Jul 7, 2021

RSV Trial in United States (RSVpreF (Group 1), RSVpreF (Group 2), RSVpreF (Group 3))

Recruiting
  • RSV
  • RSVpreF (Group 1)
  • +3 more
  • Miami Lakes, Florida
  • +18 more
Mar 10, 2022

Coronavirus Infections, Healthy Trial in Ribeirão Preto (NDV-HXP-S 1µg, NDV-HXP-S 3µg, NDV-HXP-S 10µg)

Recruiting
  • Coronavirus Infections
  • Healthy
  • NDV-HXP-S 1μg (Stage A)
  • +31 more
  • Ribeirão Preto, São Paulo, Brazil
    Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto
Aug 4, 2021

Dengue Fever Trial in United States (TAK-003, Placebo)

Completed
Has Results
  • Dengue Fever
  • TAK-003
  • Placebo
  • Huntsville, Alabama
  • +13 more
Oct 15, 2020

Smallpox Trial in United States (FD MVA-BN)

Completed
Has Results
  • Smallpox
  • FD MVA-BN
  • Birmingham, Alabama
  • +11 more
May 5, 2021

Pneumococcal Disease Trial in United States (20vPnC, 13vPnC)

Completed
Has Results
  • Pneumococcal Disease
  • 20vPnC
  • 13vPnC
  • Anaheim, California
  • +20 more
Nov 3, 2020

Poliomyelitis Trial in Kunming (sIPV batch 1, sIPV batch 2, sIPV batch 3)

Completed
  • Poliomyelitis
  • sIPV batch 1
  • +2 more
  • Kunming, Yunnan, China
    Disease prevention and control center of Yunnan province
Jan 8, 2020

Poliomyelitis Trial in Dhaka (SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot A, SII Inactivated Salk Polio Vaccine

Recruiting
  • Poliomyelitis
  • SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot A
  • +3 more
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Disease Research, Bangladesh
Dec 24, 2022

Pneumococcal Disease Trial in United States (V116, PPSV23)

Not yet recruiting
  • Pneumococcal Disease
  • V116
  • PPSV23
  • (no location specified)
Jul 12, 2022

Influenza, Human Trial (Investigational aQIVc, licensed QIV1, licensed QIV2)

Not yet recruiting
  • Influenza, Human
  • Investigational aQIVc
  • +2 more
  • (no location specified)
Aug 28, 2023

Meningitis, Meningococcal Meningitis, Meningococcal Infections Trial in United States (Meningococcal Polysaccharide (Serogroups

Completed
Has Results
  • Meningitis
  • +2 more
  • Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
  • Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
  • Birmingham, Alabama
  • +88 more
Mar 24, 2022

Autism Spectrum Disorder Trial (propofol combined with esketamine, propofol-sufentanil)

Not yet recruiting
  • Autism Spectrum Disorder
  • (no location specified)
Jul 17, 2023

Influenza Trial in United States (FluBlok®, Placebo)

Completed
Has Results
  • Influenza
  • FluBlok®
  • Placebo
  • Beverly Hills, California
  • +23 more
Mar 24, 2022

Yellow Fever Trial in Banjul, Bamako (SII Yellow Fever Vaccine, STAMARIL®)

Not yet recruiting
  • Yellow Fever
  • SII Yellow Fever Vaccine
  • STAMARIL®
  • Banjul, Gambia
  • +1 more
Jul 1, 2022

Physical Conditioning Trial in New York (Health Fair, Pedometer, Text Messaging)

Active, not recruiting
  • Physical Conditioning
  • Health Fair
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 25, 2023